Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Glucotrack (GCTK) Shares Issued (2011 - 2024)

Glucotrack (GCTK) reported Shares Issued of -$400000.0 for Q3 2024, down 103.07% quarter-over-quarter from $13.0 million in Q1 2020.

Glucotrack (GCTK) has 7 years of Shares Issued data on file, last reported at -$400000.0 in Q3 2024.

  • For the quarter ending Q3 2024, Shares Issued changed N/A year-over-year to -$400000.0; the trailing twelve-month figure through Dec 2024 stood at -$400000.0 (changed N/A YoY), and the FY2025 full-year result was $3.5 million, up 3444.0% from the prior year.
  • Shares Issued for Q3 2024 stood at -$400000.0, down from $13.0 million in the prior quarter.
  • Across five years, Shares Issued topped out at $13.0 million in Q1 2020 and bottomed at -$400000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 121.80 Mn
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 7.43 Mn
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 5.50 Mn
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn -
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 3.90 Mn
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 11.72 Mn
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 8.00 Mn
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 18.52 Mn
10 Glucotrack 290,858.33 -7.09 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2024 -400,000.00
Sep 30, 2024 -400,000.00
Mar 31, 2020 13.01 Mn
Mar 31, 2020 13.01 Mn
Dec 31, 2019 -4.13 Mn
Dec 31, 2019 -4.13 Mn
Jun 30, 2019 -716,621.00
Jun 30, 2019 -716,621.00
Mar 31, 2019 750,116.00
Mar 31, 2019 750,116.00
Dec 31, 2018 139,416.00
Dec 31, 2018 139,416.00
Sep 30, 2018 1.25 Mn
Sep 30, 2018 1.25 Mn
Jun 30, 2018 545,048.00
Jun 30, 2018 545,048.00
Mar 31, 2018 773,302.00
Mar 31, 2018 773,302.00
Dec 31, 2016 8.83 Mn
Dec 31, 2016 8.83 Mn
Jun 30, 2013 -671,762.00
Jun 30, 2013 -671,762.00
Mar 31, 2013 2.09 Mn
Mar 31, 2013 2.09 Mn
Dec 31, 2011 -1,214.00
Dec 31, 2011 -1,214.00
Sep 30, 2011 1.47 Mn
Sep 30, 2011 1.47 Mn
Jun 30, 2011 371,748.00
Jun 30, 2011 371,748.00
Mar 31, 2011 563,081.00
Mar 31, 2011 563,081.00